trial
as of 2026-07-01Horyzons: Implementation and Integration in Clinical Practice
NCTId NCT06002958
at a glance
— · Terminated
Enrollment 52 (actual)
Sponsored by University of North Carolina, Chapel Hill
Primary completion 2024-10-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Terminated
Enrollment
52 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2024-01-08
Primary completion
2024-10-31
Eligibility
ALL · 16 Years · 35 Years
Interventions & indications
Sponsors
University of North Carolina, Chapel HillLead Sponsor
Investigators
3
David L. Penn, PhDPrincipal Investigator
Diana O. Perkins, MD, MPHPrincipal Investigator
Felice Reddy, PhDPrincipal Investigator
Sites
1 total
Chapel Hill, United States
Facts & assertions
4 sourced
Enrollment
52
Phase
NA
Primary Completion Date
2024-10-31
Status
TERMINATED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
indication
indication
indication
investigator